Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study

被引:231
|
作者
Albrand, G
Munoz, F
Sornay-Rendu, E
DuBoeuf, F
Delmas, PD
机构
[1] INSERM, Res Unit 403, F-69008 Lyon, France
[2] Univ Lyon 1, F-69365 Lyon, France
关键词
osteoporosis; fracture; clinical risk factors; epidemiology;
D O I
10.1016/S8756-3282(02)00919-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several epidemiological studies have identified clinical factors that predict the risk of hip fractures in elderly women independently of the level of bone mineral density (BMD), such as low body weight, history of fractures, and clinical risk factors for falls. Their relevance in predicting all fragility fractures in all postmenopausal women, including younger ones, is unknown. The objective of this study was to identify independent predictors of all osteoporosis-related fractures in healthy postmenopausal women. We prospectively followed for 5.3 +/- 1.1 years a cohort of 672 healthy postmenopausal women (mean age 59.1 +/- 9.8 years). Information on social and professional conditions, demographic data, current and past medical history, fracture history, medication use, alcohol consumption, caffeine consumption, daily calcium intake, cigarette smoking, family history of fracture, and past and recent physical activity was obtained. Anthropometric and total hip bone mineral density measurements were made. Incident falls and fractures were ascertained every year. We observed 81 osteoporotic fractures (annual incidence, 21 per 1000 women/year). The final model consisted of seven independent predictors of incident osteoporotic fractures: age greater than or equal to 65 years, odds ratio estimate (OR), 1.90 [95% confidence interval (CI) 1.04-3.46], past falls, OR, 1.76 (CI 1.00-3.09), total hip bone mineral density (BMD) less than or equal to 0.736 g/cm(2), OR, 3.15 (CI 1.75-5.66), left grip strength less than or equal to 0.60 bar, OR, 2.05 (CI 1.15-3.64), maternal history of fracture, OR, 1.77 (CI 1.01-3.09), low physical activity, OR, 2.08 (CI 1.17-3.69), and personal history of fragility fracture, OR, 3.33 (CI 1.75-5.66). In contrast, body weight, weight loss, height loss, smoking, neuromuscular coordination assessed by three tests, and hormone replacement therapy were not independent predictors of all fragility fractures after adjustment for all variables. We found that some-but not all-previously reported clinical risk factors for skeletal fragility predicted all fragility fractures independently of BMD in healthy postmenopausal women, although they differed somewhat from those predicting specifically hip fractures in elderly women. These risk factors appear to reflect quality of bone structure (previous fragility fracture), lifestyle habits (physical activity), muscle function and health status (grip strength), heredity (maternal history of fracture), falls, and aging. Measurements of these variables should be included in the clinical assessment of the risk of osteoporotic fractures in postmenopausal women. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 50 条
  • [41] Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures
    Lucinda Strycker Orsini
    Matthew D. Rousculp
    Stacey R. Long
    Shaohung Wang
    Osteoporosis International, 2005, 16 : 359 - 371
  • [42] Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study
    Gineyts, E.
    Munoz, F.
    Bertholon, C.
    Sornay-Rendu, E.
    Chapurlat, R.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (02) : 243 - 250
  • [43] Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study
    E. Gineyts
    F. Munoz
    C. Bertholon
    E. Sornay-Rendu
    R. Chapurlat
    Osteoporosis International, 2010, 21 : 243 - 250
  • [44] The management of osteoporosis-related fractures: A survey of orthopaedic surgeons' practice
    Pal, B
    Morris, J
    Muddu, B
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (01) : 61 - 62
  • [45] Management of osteoporosis-related bone fractures: an integrated concept of care
    Carsten Strassberger
    Leonore Unger
    Andreas T. Weber
    Alexander Defer
    Felix A. Bonnaire
    Archives of Orthopaedic and Trauma Surgery, 2010, 130 : 103 - 109
  • [46] The incidence and residual lifetime risk of osteoporosis-related fractures in Korea
    Chanmi Park
    Yong-Chan Ha
    Sunmee Jang
    Suhyun Jang
    Hyun-Koo Yoon
    Young-Kyun Lee
    Journal of Bone and Mineral Metabolism, 2011, 29 : 744 - 751
  • [47] Projection of osteoporosis-related fractures and costs in China: 2010–2050
    L. Si
    T. M. Winzenberg
    Q. Jiang
    M. Chen
    A. J. Palmer
    Osteoporosis International, 2015, 26 : 1929 - 1937
  • [48] Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study
    Clapham, E.
    Boden, R.
    Reutfors, J.
    Svensson, T.
    Ramcharran, D.
    Qiu, H.
    Kileer, H.
    Bahmanyar, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2020, 141 (01) : 74 - 83
  • [49] Factors related with osteoporosis treatment in postmenopausal women
    Montagner Rossi, Lia Mara
    Copes, Rafaela Martinez
    Dal Osto, Leo Canterle
    Flores, Clovis
    Comim, Fabio Vasconcellos
    Premaor, Melissa Orlandin
    MEDICINE, 2018, 97 (28)
  • [50] Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy
    Hema N. Viswanathan
    Jeffrey R. Curtis
    Jingbo Yu
    Jeffrey White
    Bradley S. Stolshek
    Claire Merinar
    Akhila Balasubramanian
    Joel D. Kallich
    John L. Adams
    Sally W. Wade
    Applied Health Economics and Health Policy, 2012, 10 (3) : 163 - 173